1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1670
  5. Art Unit 1675
  6. Examiner Dutt

Examiner Dutt Aditi

1675-DUTT-ADITI

Employment Information

Art Unit:1675 — Drug, bio-affecting and body treating compositions
Group:1670 — Virology, Viral Immunology, And Viral Pathogens, Neurology, Receptors, Cytokines & Recombinant Hormones and Immunoassays and related devices
Classes: 424 — Drug, bio-affecting and body treating compositions
514 — Drug, bio-affecting and body treating compositions
435 — Chemistry: molecular biology and microbiology
530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
436 — Chemistry: analytical and immunological testing
Phone:(571) 272-9037
Email:aditi.dutt@uspto.gov
Location:VA 22314
Title:Pat Examnr (Biolgy)
Service:20 years
Grade:GS-13

Grant Rate and Difficulty Ranking

88
3-Year Grant rate: 36% over 135 cases
Difficulty: Very Hard
Difficulty Percentile: 88th

With Examiner Dutt, you have a 36% chance of getting an issued patent by 3 years after the first office action. Examiner Dutt is a very hard examiner and in the 88th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Dutt, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1675

Examiner Dutt's grant rate is lower than that of Art Unit 1675 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Dutt 2.0
Art Unit 1675 1.6

Interview Benefit

Grant Rate without Interview

Examiner Dutt has granted 39 of 114 cases without any applicant-requested interviews for a grant rate of 34%.

Grant Rate with Interview

Examiner Dutt has granted 9 of 21 cases with at least one applicant-requested interview for a grant rate of 43%.

Interview Benefit

With Examiner Dutt, conducting an interview increases your chance of getting a patent granted by 26%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
17853108 Anti-Secretogranin Iii (Scg3) Antibodies And Uses Thereof Rejection information available with a Premium Stats subscription. See our pricing. Abandoned View
15034766 Vh4 Antibodies Against Gray Matter Neuron And Astrocyte Abandoned View
17613310 Norovirus-Binding Peptide Patented View
18686041 Recombinant Protein Of Nerve Growth Factor Mutant And Use Thereof Abandoned View
17850383 Cgrp Antagonists And Clostridial Derivatives For The Treatment Of Neuropsychiatric And Neurological Disorders Abandoned View
16768187 Body Fluid Antibody Biomarker For Highly Sensitive Detection Of Risk Of Onset Of Cerebral Infarction Patented View
16329659 Methods And Compositions For Spinal Cord Cells Abandoned View
16457267 Monovalent Blood Brain Barrier Shuttle Modules Abandoned View
18455179 Methods Of Treating Cervical Dystonia In A Subject Having Underlying Condition(S) Abandoned View
17126351 Method Of Effecting Neuroprotection Using Soluble Neuregulin Isoforms Abandoned View
18521777 Methods Of Treating An Optic Disease In A Subject Abandoned View
16769743 Antibodies, Compositions For Use In Detecting Or Capturing A Polypeptide In A Sample, And Methods For Detecting Or Capturing A Polypeptide In A Sample Patented View
17041050 Method For Differentiating Motor Neurons From Tonsil-Derived Mesenchymal Stem Cells Abandoned View
16634869 Pharmaceutical Composition For Preventing Or Treating Neurodegenerative Disease, Containing, As Active Ingredients, Cyclodextrin And Stem Cells In Which Vegf Is Overexpressed Abandoned View
16119656 Cyclin-Dependent Kinase 5 (Cdk5) Inhibitory Peptides Patented View
16782094 Cladribine Regimen For Treating Multiple Sclerosis Patented View
17051635 Anti-Carbonic Anhydrase Ix Antibody Patented View
17013974 Methods For The Identification, Assessment, Prevention, And Treatment Of Neurological Disorders And Diseases Abandoned View
16612141 Gut Microbiome Function Predicts Response To Anti-Integrin Biologic Therapy In Inflammatory Bowel Diseases Abandoned View
15781681 Compositions And Methods For Internalizing Enzymes Abandoned View
15768736 Microfluidic Model Of The Blood Brain Barrier Abandoned View
17242780 Antibody Based Reagents That Specifically Recognize Neurodegenerative Disease Related Forms Of The Protein Tdp-43 Patented View
15772572 Method For Vaccination Against A Self-Antigen In A Human Patient Patented View
17481528 Method Of Treating Peripheral Nerve Disorders Abandoned View
16447106 Re-Use Of Enzymes In In Vitro Glycoengineering Of Antibodies Patented View
17012159 Method Of Effecting Neuroprotection Using Soluble Neuregulin Isoforms Patented View
17391990 Compositions And Methods For Determining Coronavirus Neutralization Titers Abandoned View
16755312 Systems And Methods For Producing Retinal Progenitors Patented View
18525736 Novel Anti-A2ap Antibodies And Uses Thereof Patented View
15352289 Development Of Spinal Cord On A Microfluidic Chip Patented View
17127913 Anti-Ryk Antibodies And Methods Of Using The Same Patented View
16512278 Stem Cell Model Of Apoe Genotype And Abeta42-Dependent Neurodegeneration And Methods Of Using The Same Abandoned View
17051413 Treatment Of Melanoma Brain Metastasis By Inhibition Of Amyloid Precursor Protein Cleavage Abandoned View
17392144 Drug Regimen For Treatment Of Cerebral Ischemia Patented View
16727131 Modulating Venuleness Of Endothelial Cells Abandoned View
17149713 Methods For Efficient Derivation Of Human Motor Neurons From Diverse Spinal Regions Patented View
16967763 Antibody Against The Endothelin Receptor Subtype A, And Uses Thereof Patented View
16899643 Allergy Antigen And Epitope Thereof Abandoned View
16923927 Fluorescent Protein Biosensor For Detection Of Kinase Activity Abandoned View
16085984 Nerve Growth Factor Fusion Protein, Preparation Method And Use Thereof Patented View
17183934 Botulinum Toxin And The Treatment Of Primary Disorders Of Mood And Affect Abandoned View
17420477 Novel Glia-Like Cells Differenatiated From Somatic Cells, Preparation Method Therefor, Cocktail Composition For Preparing Same, Cell Therapeutic Agent For Preventing Or Treating Neurological Disorders, Comprising Same, And Method For Preventing And Treating Neurological Disorders By Administering Same Abandoned View
16092561 Biomarkers For Monitoring Immune Transformation Patented View
16628918 Screening Platform To Identify Therapeutic Drugs Or Agents For Treatment Of Alzheimer's Disease Abandoned View
15544604 Method For Producing Nervous System Cells Patented View
16334691 Harnessing Protein-Based Drugs Comprising An Anchor Domain For Use On The Ocular Surface Abandoned View
15953197 Personalized 3d Neural Culture System For Generating Human Oligodendrocytes And Studying Myelination In Vitro Patented View
16335812 Assay For Diagnosing Alzheimer's Disease Patented View
16446066 Molecules That Bind To And Stabilize Triggering Receptor Expressed On Myeloid Cells 2 (Trem2) Abandoned View
16079932 Materials And Methods For Mitigating Immune-Sensitization Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.